Approximately 1 year after beginning treatment with omalizumab, a 68-year-old man who had received a diagnosis of idiopathic urticaria and angioedema developed pain and swelling in the small joints of his hands and wrists.
While anti-tumor necrosis factor (TNF) inhibitors are effective treatments for patients with several inflammatory diseases, they may be associated with new onset psoriatic eruptions or paradoxical worsening of preexisting psoriatic skin disease. In an interview with The Dermatologist, Lourdes M.…
The FDA approved halobetasol propionate tazarotene 0.01%/0.045% lotion for the treatment of plaque psoriasis. Lawrence Green, MD, spoke with The Dermatologist about how this therapy will benefit patients with mild disease.
A 51-year-old African American woman with a more than 20-year history of severe plaque psoriasis presented to the clinic due to a flare-up of her symptoms, including moderate joint pain (but no muscle aches or weakness), enlargement of plaques, severe pruritus, flaking, and erythema. Her family…
A 29-day-old girl was referred to a dermatology practice by a general pediatrics clinic after having been evaluated in the emergency department for a scattered erythematous eruption on her scalp, face, neck, legs, and abdomen for 4 days.
The limited treatment options available and lack of research on how HS affects patients with skin of color has left many patients struggling to receive the appropriate care they need to improve their quality of life.
Stay in the know. Autoimmune Learning Network Newsletter